Kuros Biosciences A.G. products

MagnetOs isn’t like other bone grafts. It grows bone even in soft tissue thanks to our unique NeedleGrip™ surface technology which provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).*†6,7 This in turn, unlocks previously untapped potential to stimulate stem cells – and form new bone throughout the graft.*8-10 The growing body of science behind NeedleGrip is called osteoimmunology. But for surgeons and their patients it means one thing: a more efficient and predictable fusion.*‡10

Fibrin-PTH (KUR-113) is the latest candidate in our pipeline – and the first ever investigational drug-biologic candidate to be evaluated for spinal fusion. It’s based on proprietary controlled-release technology that combines the well-established mechanism of the bone growth factor parathyroid hormone (PTH) with the natural healing matrix, known as fibrin.* Once implanted, Fibrin-PTH promotes spinal fusion by increasing the number and lifespan of bone-forming (osteogenic) cells in the fusion space. Fibrin-PTH is also the first investigational drug-biologic to be compatible with narrow gauge cannulas for truly non-invasive surgical procedures – with the potential to be a true game changer once commercially available.